The weekly litigation news digest is live. Subscribe now

Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome - EP3710058

The patent EP3710058 was granted to GW Research on Oct 9, 2024. The application was originally filed on Nov 15, 2018 under application number EP18808075A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3710058

GW RESEARCH
Application Number
EP18808075A
Filing Date
Nov 15, 2018
Status
Granted And Under Opposition
Sep 6, 2024
Publication Date
Oct 9, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBJul 8, 2025KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTGB2531282
INTERNATIONAL-SEARCH-REPORTUS2017224634
OPPOSITIONWO2016059403

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents